Tauriga Sciences Inc. Retains International Law Firm Nixon Peabody LLP as Legal Advisor for the Structuring of Future Business Transactions

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, Oct. 14, 2013 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTCQB:TAUG) or (“Tauriga” or “the Company”), a diversified company focused on generating profitable revenues through license agreements and evaluating potentially lucrative acquisition targets in an industry agnostic manner, has today announced the retention of the international law firm Nixon Peabody LLP (“Nixon Peabody) to advise the Company on both the structuring future business transactions and the evaluation of intellectual property (“IP”). The Company is currently contemplating and negotiating potential business opportunities and is pleased to have retained such an experienced law firm with vast resources as Nixon Peabody. The Company anticipates that future business opportunities and transactions may include but are not limited to: purchase orders from existing license agreement, entering into new license agreements, establishment of joint venture partnerships, direct investments (equity stakes), and merger and acquisition activity. The Company will disclose to shareholders, via a press release, when and if a contemplated business transaction is consummated.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC